Endovascular Treatment of Intracranial Arteriovenous Malformations with Onyx: Technical Aspects

References

1. ↵
   Ogilvy CS, Stieg PE, Awad I, et al. AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 2001;32:1458–71

   FREE Full Text
2. ↵
   TerBrugge KG. Brain AVM. Interventional Neuroradiol 2003;9(suppl 2):107–08
3. ↵
   Schaller C, Schramm J, Haun D. Significance of factors contributing to surgical complications and to late outcome after elective surgery of cerebral arteriovenous malformations. J Neurol Neurosurg Psychiatry 1998;65:547–54

   Abstract/FREE Full Text
4. ↵
   Pollock BE, Gorman DA, Coffey RJ. Patient outcomes after arteriovenous malformation radiosurgical management: results based on a 5- to 14-year follow-up study. Neurosurgery 2003;52:1291–96

   PubMedWeb of Science
5. ↵
   Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65:476–83

   PubMedWeb of Science
6. ↵
   Pasqualin A, Barone G, Cioffi F, et al. The relevance of anatomic and hemodynamic factors to a classification of cerebral arteriovenous malformations. Neurosurgery 1991;28:370–79

   CrossRefPubMedWeb of Science
7. ↵
   Taki W, Yonekawa Y, Iwata H, et al. A new liquid material for embolization of arteriovenous malformations. AJNR Am J Neuroradiol 1991;11:163–68
8. ↵
   Terada T, Nakamura Y, Nakai K, et al. Embolization of arteriovenous malformations with peripheral aneurysms using ethylene vinyl alcohol copolymer: report of three cases. J Neurosurg 1991;75:655–60

   PubMed
9. ↵
   Molyneux AJ, Coley S. Embolization of spinal cord arteriovenous malformations with ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide (Onyx liquid embolic system). J Neurosurg 2000;93:304–08

   PubMedWeb of Science
10. ↵
    Chaloupka JC, Huddle DC, Alderman J, et al. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. AJNR Am J Neuroradiol 1999;20:401–10

    Abstract/FREE Full Text
11. ↵
    Muramaya Y, Vinuela F, Ulhoa A, et al. Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile. Neurosurgery 1998;43:1164–75

    CrossRefPubMedWeb of Science
12. ↵
    Valavanis A, Yaşargil MG. The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg 1998;24:131–214

    PubMed
13. ↵
    Joint Writing Group of the Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Joint Section on Cerebrovascular Neurosurgery a Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons; Section of Stroke and the Section of Interventional Neurology of the American Academy of Neurology. Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke 2001;32:1430–42

    Abstract/FREE Full Text
14. ↵
    Akin ED, Perkins E, Ross IB. Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with n-butyl cyanoacrylate used for embolization of vessels in an arteriovenous malformation resection model in swine. J Neurosurg 2003;98:366–70

    PubMed
15. ↵
    Debrun GM, Aletich V, Ausman JI, et al. Embolization of nidus of brain arteriovenous malformations with n-butyl cyanoacrylate. Neurosurgery 1997;40:112–21

    CrossRefPubMed
16. ↵
    Tokunaga K, Kinugasa K, Meguro T, et al. Curative treatment of cerebral arteriovenous malformations by embolisation using cellulose acetate polymer followed by surgical resection. J Clin Neurosci 2000;7(suppl 1):1–5
17. DeMeritt JS, Pile-Spellman, Mast H. Outcome analysis of preoperative embolization with n-butyl cyanoacrylate in cerebral arteriovenous malformations. AJNR Am J Neuroradiol 1995;16:1801–07

    Abstract
18. Frizzel RT, Fisher WS 3rd. Cure, morbidity and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period. Neurosurgery 1995;37:1039–40
19. Wallace RC, Flom RA, Khayata MH, et al. The safety and effectiveness of brain arteriovenous malformation embolization using acrylic and particles: the experience of a single institution. Neurosurgery 1995;37:606–18

    PubMed
20. Grzyska U, Neumaier Probst E, et al. Differentialtherapie zerebraler Angiome. Wien Med Wochenschr 1997;7/8:186–93
21. Wikholm G, Lundquist C, Svedsen P. Transarterial embolization of cerebral arteriovenous malformations. How few can you do? Interventional Neuroradiol 1997;3:119–23
22. Yakes WF, Krauth L, Ecklund J, et al. Ethanol endovascular management of brain arteriovenous malformations: initial results. Neurosurgery 1997;49:1145–52
23. Sorimachi T, Koike T, Takeuchi S, et al. Embolization of cerebral arteriovenous malformations achieved with polyvinyl alcohol particles: angiographic reappearance and complications. AJNR Am J Neuroradiol 1999;20:1323–28

    Abstract/FREE Full Text
24. Rosenwasser RH, Armonda RA. Embolization as palliative or definitive therapy. In: Jafar JJ, Awad IA, Rosenwasser RH (eds), Vascular Malformations of the Central Nervous System. FPhiladelphia: Lippincott, Williams & Wilkins,2000 :405–12
25. Liu HM, Huang YC, Wang YH. Embolization of cerebral arteriovenous malformations with n-butyl-2-cyanoacrylate. J Formos Med Assoc 2000;99:906–13

    PubMed
26. Song JK, Eskridge JM, Chung EC, et al. Preoperative embolization of cerebral arteriovenous malformations with silk sutures: analysis and clinical correlation of complications revealed on computerized tomography scanning. J Neurosurg 2000;92:955–60

    PubMed
27. Li T, Duan C, Wang Q, et al. Endovascular embolization of cerebral arteriovenous malformation. Zhonghua Yi Xue Za Zhi 2002;82:654–56

    PubMed
28. Meisel HJ, Mansmann U, Alvarez H, et al. Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir (Wien) 2002;144:879–87

    CrossRefPubMed
29. n-BCA Trail Investigators. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 2002;23:748–55

    Abstract/FREE Full Text
30. ↵
    TerBrugge KG. Endovascular treatment of brain AVM. Interventional Neuroradiol 2003;9(suppl 2):109–11
31. ↵
    Simonetti L, Cenni P, de Santis F, et al. Prime esperienze di embolizzazione di MAV cerebrali con Onyx. Rivista di Neuroradiologica 2001;14(suppl 3):251–56
32. ↵
    Florio F, Lauriola W, Nardella M, et al. Endovascular treatment of intracranial arteriovenous malformations with Onyx embolization: preliminary experience. Radiol Med Torino 2003;106:512–20
33. ↵
    Cekirge S, Saatci I, Arat A. Long-term intranidal Onyx injection in the endovascular treatment of pial brain AVMs: description of a new technique and philosophy aimed at cure. J Neurosurg 2002;96:173

    PubMedWeb of Science
34. ↵
    Niemann DB, Molyneux AJ. Embolization of brain AVMs with ethylene-vinyl-alcohol copolymer dissolved in DMSO (Onyx liquid embolic system): evidence in a prospective series of 31 patients. J Neurosurg 2002;96:171
35. ↵
    Jahan R, Murayama Y, Gobin YP. Embolization of arteriovenous malformations with Onyx: clinicopathological experience in 23 patients. Neurosurgery 2001;48:984–95

    CrossRefPubMedWeb of Science
36. ↵
    Hamada J, Kai Y, Morioka M, et al. A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience. J Neurosurg 2002;97:881–88

    PubMed